AGA Family of Websites:

New AGA guidelines: A targeted approach to IBS-C and IBS-D treatment

Our newest clinical guidelines outline when to use which IBS drug based on your patientsā€™ symptoms.
IBS Pharmacological Treatment Flowchart
IBS Pharmacological Treatment Flowchart

AGA has published two new treatment guidelines in Gastroenterology providing a personalized approach for treating your patients with approved drug treatments for irritable bowel syndrome (IBS) with constipation (IBS-C) or IBS with diarrhea (IBS-D).

The guidelines outline, for the first time, when to use newly introduced IBS drugs, when to rely on old drugs approved by the FDA and when to use over the counter drugs. With more treatments available, you can now tailor a personalized approach based on the symptoms your IBS patient is experiencing.

Join us for a webinar on each of the guidelines

Please join the guideline authors for Gastro Bites on IBS-C and IBS-D. During each of the 30-minute webinars, they will explain the guidance in greater detail and answer your questions about applying these guidelines in your practice.

  • Register for Gastro Bites: Irritable bowel syndrome with constipation (IBS-C) taking place on Thursday, July 7 at noon EDT
  • Register for Gastro Bites:Ā Irritable bowel syndrome with diarrhea (IBS-D) taking place on Thursday, July 21 at noonĀ EDT


Additional Resources

AGA Clinical Guidance
Evidence-based recommendations.

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.